Pascal E. R. Girin - 01 Oct 2025 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Director
Issuer ticker: CLPT
Reported as of: 01 Oct 2025
Net transaction value: +$6,864
SEC form: 4
Accepted by SEC: 02 Oct 2025, 19:06:53 UTC
Prior SEC filing: 02 Jul 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin

Key filing fact

Pascal E. R. Girin filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 02 Oct 2025.

Key facts

This page summarizes Pascal E. R. Girin's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Oct 2025, 19:06.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: +$6,864.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001329811 Primary reporting owner

Girin Pascal E R

Relationship: Director
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin
Signature date: 02 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Award

Transaction value: $6,864
Shares: +315
Change %: +0.33%
Price: $21.79
Shares after: 96,949
Date: 01 Oct 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2025.